← Back
$AVNS All transactions

AVANOS MEDICAL, INC.

▲ BUY
6 / 10

Conviction

$ Value

$440K

Shares

40,000

Price

$11

Filed

Aug 15

Why this score? (6/10)
  • Open market buy (+3)
  • Trade value >= $250K (+1)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

BLACKFORD GARY

Title

CIK

0001156320

Roles

Director

Transaction Details

Transaction Date

2025-08-13

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

40,000

Footnotes

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.94 to $11.01, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.98 to $11.04, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | These shares are held in trusts for the benefit of certain immediate family members of the Reporting Person. The Reporting Person is co-trustee of such trusts. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

Filing Info

Accession No.

0001606498-25-000111

Form Type

4

Issuer CIK

0001606498

BLACKFORD GARY's History

Date Ticker Type Value
2025-08-13 AVNS $220K
2025-08-13 AVNS $440K

Other Insiders at AVNS (90d)

Insider Bought Sold Last
Pacitti David
Chief Executive Officer
2026-04-14
Delgado Sigfrido
SVP, Operations
2026-03-13
Galovan Scott Michael
SVP, Chief Financial Officer
2026-03-13